Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants

被引:147
作者
Henry, LK
Field, JR
Adkins, EM
Parnas, ML
Vaughan, RA
Zou, MF
Newman, AH
Blakely, RD
机构
[1] Vanderbilt Univ, Ctr Med, Ctr Mol Neurosci, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Ctr Med, Dept Pharmacol, Nashville, TN 37232 USA
[3] Univ Utah, Ctr Med, Dept Pathol, Salt Lake City, UT 84112 USA
[4] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58203 USA
[5] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA
关键词
D O I
10.1074/jbc.M505055200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In previous studies examining the structural determinants of antidepressant and substrate recognition by serotonin transporters (SERTs), we identified Tyr-95 in transmembrane segment 1 (TM1) of human SERT as a major determinant of binding for several antagonists, including racemic citalopram ((RS)-CIT). Here we described a separate site in hSERT TM3 (Ile-172) that impacts (RS)-CIT recognition when switched to the corresponding Drosophila SERT residue (I172M). The hSERT I172M mutant displays a marked loss of inhibitor potency for multiple inhibitors such as (RS)-CIT, clomipramine, RTI-55, fluoxetine, cocaine, nisoxetine, mazindol, and nomifensine, whereas recognition of substrates, including serotonin and 3,4-methylenedioxymethamphetamine, is unaffected. Selectivity for antagonist interactions is evident with this substitution because the potencies of the antidepressants tianeptine and paroxetine are unchanged. Reduced cocaine analog recognition was verified in photoaffinity labeling studies using [I-125] MFZ 2-24. In contrast to the I172M substitution, other substitutions at this position significantly affected substrate recognition and/or transport activity. Additionally, the mouse mutation (mSERT I172M) exhibits similar selective changes in inhibitor potency. Unlike hSERT or mSERT, analogous substitutions in mouse dopamine transporter (V152M) or human norepinephrine transporter (V148M) result in transporters that bind substrate but are deficient in the subsequent translocation of the substrate. A double mutant hSERT Y95F/ I172M had a synergistic impact on ( RS)-CIT recognition (similar to 10,000-fold decrease in ( RS)-CIT potency) in the context of normal serotonin recognition. The less active enantiomer (R)-CIT responded to the I172M substitution like (S)-CIT but was relatively insensitive to the Y95F substitution and did not display a synergistic loss at Y95F/ I172M. An hSERT mutant with single cysteine substitutions in TM1 and TM3 resulted in formation of a high affinity cadmium metal coordination site, suggesting proximity of these domains in the tertiary structure of SERT. These studies provided evidence for distinct binding sites coordinating SERT antagonists and revealed a close interaction between TM1 and TM3 differentially targeted by stereoisomers of CIT.
引用
收藏
页码:2012 / 2023
页数:12
相关论文
共 36 条
[1]   Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition [J].
Adkins, EM ;
Barker, EL ;
Blakely, RD .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :514-523
[2]   [H-3] COCAINE LABELS A BINDING-SITE ASSOCIATED WITH THE SEROTONIN TRANSPORTER IN GUINEA-PIG BRAIN - ALLOSTERIC MODULATION BY PAROXETINE [J].
AKUNNE, HC ;
DECOSTA, BR ;
JACOBSON, AE ;
RICE, KC ;
ROTHMAN, RB .
NEUROCHEMICAL RESEARCH, 1992, 17 (12) :1275-1283
[3]  
Barker EL, 1999, J NEUROSCI, V19, P4705
[4]   High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis - An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol [J].
Barker, EL ;
Perlman, MA ;
Adkins, EM ;
Houlihan, WJ ;
Pristupa, ZB ;
Niznik, HB ;
Blakely, RD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) :19459-19468
[5]  
BARKER EL, 1994, MOL PHARMACOL, V46, P799
[6]  
BARKER EL, 1995, PSYCHOPHARMACOLOGY 4
[7]  
Barker EL, 1998, METHOD ENZYMOL, V296, P475
[8]   Permeation and gating residues in serotonin transporter [J].
Chen, JG ;
Rudnick, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1044-1049
[9]   The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding [J].
Chen, JG ;
Sachpatzidis, A ;
Rudnick, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28321-28327
[10]   Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter [J].
Gaffaney, JD ;
Vaughan, RA .
MOLECULAR PHARMACOLOGY, 2004, 65 (03) :692-701